1. Home
  2. EARN vs NYXH Comparison

EARN vs NYXH Comparison

Compare EARN & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • NYXH
  • Stock Information
  • Founded
  • EARN 2012
  • NYXH 2009
  • Country
  • EARN United States
  • NYXH Belgium
  • Employees
  • EARN N/A
  • NYXH N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • NYXH Medical/Dental Instruments
  • Sector
  • EARN Real Estate
  • NYXH Health Care
  • Exchange
  • EARN Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • EARN 223.5M
  • NYXH 250.5M
  • IPO Year
  • EARN 2013
  • NYXH 2021
  • Fundamental
  • Price
  • EARN $5.87
  • NYXH $6.43
  • Analyst Decision
  • EARN Buy
  • NYXH Strong Buy
  • Analyst Count
  • EARN 2
  • NYXH 3
  • Target Price
  • EARN $6.13
  • NYXH $15.00
  • AVG Volume (30 Days)
  • EARN 385.7K
  • NYXH 167.7K
  • Earning Date
  • EARN 08-19-2025
  • NYXH 08-18-2025
  • Dividend Yield
  • EARN 16.44%
  • NYXH N/A
  • EPS Growth
  • EARN N/A
  • NYXH N/A
  • EPS
  • EARN N/A
  • NYXH N/A
  • Revenue
  • EARN $35,893,000.00
  • NYXH $5,793,306.00
  • Revenue This Year
  • EARN $3.72
  • NYXH $209.22
  • Revenue Next Year
  • EARN $18.59
  • NYXH $219.37
  • P/E Ratio
  • EARN N/A
  • NYXH N/A
  • Revenue Growth
  • EARN 43.30
  • NYXH 2.94
  • 52 Week Low
  • EARN $4.33
  • NYXH $5.55
  • 52 Week High
  • EARN $7.11
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • EARN 57.65
  • NYXH 40.38
  • Support Level
  • EARN $5.59
  • NYXH $6.02
  • Resistance Level
  • EARN $5.76
  • NYXH $6.85
  • Average True Range (ATR)
  • EARN 0.12
  • NYXH 0.55
  • MACD
  • EARN 0.02
  • NYXH -0.06
  • Stochastic Oscillator
  • EARN 94.03
  • NYXH 16.29

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics, and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: